Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABRAFENIB vs RITONAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABRAFENIB vs RITONAVIR: Safety Overview

Metric DABRAFENIB RITONAVIR
Total FAERS Reports 19,305 11,980
Deaths Reported 4,165 1,190
Death Rate 21.6% 9.9%
Hospitalizations 5,325 2,925
Average Patient Age 58.3 yrs 43.8 yrs
% Female Patients 48.0% 43.8%
FDA Approval Date Mar 16, 2023 Dec 3, 2020
Manufacturer Novartis Pharmaceuticals Corporation AbbVie Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued